Ortho Clinical Gains CE Mark for Cardiac Assay

Ortho Clinical Diagnostics has received the CE Mark for an improved version of its Vitros NT-proBNP II product, a diagnostic used to identify heart failure.

The assay is also designed for risk stratification — grouping patients based on their risk and rising risk — of acute coronary syndrome and heart failure.

The enhanced version of the assay has improved assay quality through the use of monoclonal antibodies and an enhanced resistance to potential interferences.